New Market Insights for Crop Biologics
Date:06-15-2018
By Nathan Danielson
American agriculture is undergoing a new wave of productivity and enhanced sustainability. While many previous advances focused on enhancing a plant’s internal ability to overcome natural challenges, this next wave focuses on the critical interactions between plants and the surrounding microbiome. In recent years, there has been a renewed emphasis on improving soil health. This next wave focuses on the interactions between a growing crop and the microbial community in and around the soil. This is an incredibly complex endeavor to identify those microbes that are beneficial in improving yield, increasing nutrient efficiency, improving abiotic stress tolerance or protecting against harmful pests and diseases.
A recently released business study “Plant Microbiome, The Next Wave in Agriculture?,” conducted by BioCognito and Farmgate Insights, takes a multifaceted look at this expanding field of agriculture. Microbial additives or “biologics” are becoming an important approach for farmers looking for ways to manage production challenges.
Companies across the agricultural spectrum are investing heavily in this new wave. Over the past five years, there has been more than $5 billion of disclosed investment in this space. “We have seen multinationals form new alliances, well known crop protection and nutrient companies purchase startups, and an explosion of innovators, all trying to be a part of the action” said Nathan Danielson, one of the report’s authors. “Companies that didn’t exist 5 and 10 years ago are raising ten of millions of dollars, and one has recently attained ‘Unicorn’ status. Meanwhile, traditional agriculture companies are pursuing different strategies such as bundling biologics with a whole suite of products or tying them with existing crop protection and fertilizers.”
While the use of biologics in specialty crops and the organic industry are ahead of row crops, with over 250 million acres planted annually this is a huge potential market. “One of our study goals was to look at the five primary field crops in the U.S. (corn, soybeans, wheat, cotton and sorghum) and analyze their unique barriers to entry and potential delivery systems for biologics,” stated co-author Paul Bertels. “We have talked with a number of growers and commodity organizations to get their perspectives on what do want to enhance adoption.”
In support of the study, the authors have created an interactive cost-benefit model for each crop to help farmers or industry assess the value of a new product. “Our models indicate value creation in excess of $8.5 billion in farmgate revenue for these five crops in the US alone. This value is largely driven by yield increases and the ability to utilize marginal land, however a number of other drivers were important. According to co-author Nathan Danielson “We used conservative assumptions in our models and still saw very significant new value creation. Beyond this, there were specific geographies and market sectors that were really exciting opportunities”.
The reward for capturing market share is enormous. Corn, cotton, soybeans, sorghum and wheat represent a significant opportunity for crop biologics.
The market study “Plant Microbiome: The Next Wave in Agriculture” provides the reader with a clear understanding of the landscape of the market place. This is accomplished through analysis on market structure and barriers to entry as well insights into market participants and those who may enter. Finally, customizable models are provided to readers to allow value determination for specific crops and geographies.